Nuveen
LAB icon

Nuveen’s Standard BioTools LAB Stock Holding History

Nuveen’s Portfolio LAB Stock Details LAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-661,204
Closed -$608K – 3803
2026
Q1 		$608K Buy
661,204
+3,992
+0.6% +$4.83K ﹤0.01% 2767
2025
Q4 		$841K Hold
657,212
– – ﹤0.01% 2690
2025
Q3 		$854K Hold
657,212
– – ﹤0.01% 2692
2025
Q2 		$789K Sell
657,212
-141,270
-18% -$157K ﹤0.01% 2700
2025
Q1 		$862K Hold
798,482
– – ﹤0.01% 2701
2024
Q4 		$1.4M Sell
798,482
-24,003
-3% -$44.7K ﹤0.01% 2540
2024
Q3 		$1.59M Buy
822,485
+39,333
+5% +$77K ﹤0.01% 2534
2024
Q2 		$1.39M Buy
+783,152
New +$1.91M ﹤0.01% 2564
2022
Q2 		– Sell
-1,599,180
Closed -$5.87M – 3382
2022
Q1 		$5.87M Sell
1,599,180
-355,906
-18% -$1.23M ﹤0.01% 1971
2021
Q4 		$7.66M Buy
1,955,086
+23,251
+1% +$109K ﹤0.01% 1847
2021
Q3 		$13.4M Buy
1,931,835
+292,032
+18% +$1.92M ﹤0.01% 1573
2021
Q2 		$10.1M Buy
1,639,803
+384,905
+31% +$2.06M ﹤0.01% 1856
2021
Q1 		$5.67M Buy
1,254,898
+57,419
+5% +$315K ﹤0.01% 2113
2020
Q4 		$7.18M Buy
1,197,479
+163,618
+16% +$1.07M ﹤0.01% 1892
2020
Q3 		$7.68M Sell
1,033,861
-83,293
-7% -$575K ﹤0.01% 1674
2020
Q2 		$4.48M Buy
1,117,154
+48,584
+5% +$169K ﹤0.01% 1960
2020
Q1 		$2.71M Sell
1,068,570
-928
-0.1% -$3.05K ﹤0.01% 2037
2019
Q4 		$3.72M Sell
1,069,498
-120,720
-10% -$425K ﹤0.01% 2142
2019
Q3 		$5.51M Buy
1,190,218
+63,977
+6% +$504K ﹤0.01% 1901
2019
Q2 		$13.9M Buy
+1,126,241
New +$14.3M 0.01% 1395

Other funds holding LAB

CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
MCO
MAK Capital One New York $714M AUM 68.07% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.91B AUM 12.68% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HBWM
Hollow Brook Wealth Management Katonah, New York $504M AUM 26.89% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Nuveen's LAB Position: Q2 2026 in Review

Nuveen sold out of Standard BioTools (LAB) in Q2 2026, closing a stake of 661,204 shares — an estimated $608K sold.

Nuveen first reported a position in LAB in Q2 2019 and held it in 20 quarters. The position peaked at $13.9M in Q2 2019. 144 funds tracked by Wall St. Rank hold LAB as of Q2 2026.

  • Nuveen reported no remaining Standard BioTools position as of Q2 2026 after selling out during the quarter.
  • Nuveen sold 661,204 Standard BioTools shares in Q2 2026, an estimated $608K.
  • Nuveen first reported a position in Standard BioTools in Q2 2019 and held it in 20 quarters.
  • Nuveen's Standard BioTools position peaked at $13.9M in Q2 2019.
  • 144 funds tracked by Wall St. Rank held Standard BioTools as of Q2 2026.

Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.